查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1770820

生物製造病毒檢測與定量市場－全球產業規模、佔有率、趨勢、機會和預測，按產品類型、技術、應用、最終用戶、地區和競爭細分，2020-2030 年預測

Biomanufacturing Viral Detection and Quantifications Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Offering Type, By Technology, By Application, By End-User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 198 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年，全球生物製造病毒檢測與定量市場規模為4.9346億美元，預計2030年將達到8.3586億美元，複合年成長率為9.14%。該市場涵蓋用於檢測和定量臨床、環境和研究樣本中病毒的試劑、儀器和診斷系統的大規模生產。生物製造融合了生物技術、分子生物學和工程學原理，能夠持續且可擴展地開發PCR、ELISA和其他分子診斷等技術所必需的工具。這些技術支援診斷試劑盒和高通量平台的創建，包括生物感測器和微流體技術，這些平台在即時診斷和實驗室環境中的應用日益廣泛。該行業在實現快速病毒檢測和測量方面發揮關鍵作用，以支持全球衛生系統的監測、診斷和應對工作。關鍵領域包括分子診斷、免疫診斷、生物感測器技術和基於細胞的分析——所有這些都有助於及時識別和管理病毒威脅。

市場概覽
預測期 2026-2030
2024年市場規模 4.9346億美元
2030年市場規模 8.3586億美元
2025-2030 年複合年成長率 9.14%
成長最快的領域 酵素連結免疫吸附試驗
最大的市場 亞太地區

關鍵市場促進因素

病毒性疾病發生率不斷上升

主要市場挑戰

快速進化的病毒

主要市場趨勢

新興傳染病防範

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球生物製造病毒檢測與定量市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品類型（消耗品、儀器、服務）
    • 依技術（PCR、ELISA、流式細胞儀、斑塊分析、其他）
    • 按應用（血液和血液製品製造、疫苗和治療劑製造、細胞和基因治療產品製造、幹細胞產品製造、組織和組織產品製造）
    • 按最終用戶（生命科學公司、檢測實驗室、CRO 和 CDMO）
    • 按公司分類（2024）
    • 按地區
  • 市場地圖

第6章：北美生物製造病毒檢測與定量市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲生物製造病毒檢測與定量市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太生物製造病毒檢測與定量市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美洲生物製造病毒檢測與定量市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲生物製造病毒檢測和定量市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章： 大環境分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Danaher Corporation
  • Merck KGaA
  • New England Biolabs
  • TAKARA HOLDINGS INC.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Sartorius AG
  • Charles River Laboratories
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 15881

The Global Biomanufacturing Viral Detection and Quantifications Market was valued at USD 493.46 million in 2024 and is projected to reach USD 835.86 million by 2030, growing at a CAGR of 9.14%. This market encompasses the large-scale production of reagents, instruments, and diagnostic systems used to detect and quantify viral agents in clinical, environmental, and research samples. Integrating biotechnological, molecular biology, and engineering principles, biomanufacturing enables the consistent and scalable development of tools essential for techniques like PCR, ELISA, and other molecular diagnostics. These technologies support the creation of diagnostic kits and high-throughput platforms, including biosensors and microfluidics, which are increasingly used in point-of-care and laboratory settings. The sector plays a critical role in enabling rapid virus detection and measurement, supporting global health systems in their surveillance, diagnosis, and response efforts. Key areas include molecular diagnostics, immunodiagnostics, biosensor technologies, and cell-based assays-all of which contribute to the timely identification and management of viral threats.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 493.46 Million
Market Size 2030USD 835.86 Million
CAGR 2025-20309.14%
Fastest Growing SegmentELISA
Largest MarketAsia Pacific

Key Market Drivers

Increasing Incidence of Viral Diseases

The growing prevalence of viral diseases is a primary driver accelerating the demand for advanced viral detection and quantification tools. As of 2024, the World Health Organization reported over 4.2 million dengue cases globally and more than 95,000 mpox (formerly monkeypox) cases since its outbreak in 2022. These figures reflect the increasing urgency for effective diagnostic tools to identify and contain viral infections early.

Biomanufactured products such as PCR kits, ELISA tests, and CRISPR-based diagnostics are vital for fast and accurate virus detection from clinical and environmental samples. These tools facilitate early diagnosis, rapid treatment initiation, and containment of infectious diseases. In settings where diseases like dengue are endemic, early quantification of viral load is essential to assess disease severity and determine appropriate clinical interventions. As new viral threats emerge, the need for deployable, high-performance diagnostic solutions continues to grow.

Key Market Challenges

Rapidly Evolving Viruses

One of the major challenges in the market is the ability of viruses to mutate rapidly, which can compromise the accuracy and reliability of diagnostic assays. Genetic mutations can affect the regions targeted by primers, probes, or antibodies, resulting in false negatives or decreased assay sensitivity.

To maintain diagnostic accuracy, biomanufacturers must continually update assay formulations to account for emerging variants. This requires ongoing investment in R&D and flexible production systems that can respond to evolving viral genomes. Ensuring optimal binding affinity and specificity under these conditions is complex and resource-intensive, posing a challenge to sustained product performance in the face of dynamic viral evolution.

Key Market Trends

Emerging Infectious Diseases Preparedness

Preparedness for emerging infectious diseases (EIDs) is shaping the future of the biomanufacturing viral detection and quantification market. This trend emphasizes the need for agile and responsive diagnostic capabilities that can be deployed during novel outbreaks.

Manufacturers are prioritizing the development of flexible diagnostic platforms that can quickly adapt to new pathogens. Scalable production and modular assay designs enable rapid shifts in manufacturing focus during global health emergencies. Fast-track regulatory approvals, collaborative efforts with public health agencies, and real-time surveillance capabilities are further reinforcing this trend.

Biomanufactured viral detection tools are not only crucial for diagnostics but also for tracking disease spread, evaluating vaccine effectiveness, and informing public health strategies during outbreaks. The growing emphasis on global health security is driving investment in platforms that support EID surveillance, detection, and response.

Key Market Players

  • Danaher Corporation
  • Merck KGaA
  • New England Biolabs
  • TAKARA HOLDINGS INC.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Sartorius AG
  • Charles River Laboratories
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc

Report Scope:

In this report, the Global Biomanufacturing Viral Detection and Quantifications Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biomanufacturing Viral Detection and Quantifications Market, By Offering Type:

  • Consumables
  • Instruments
  • Services

Biomanufacturing Viral Detection and Quantifications Market, By Technology:

  • PCR
  • ELISA
  • Flow Cytometry
  • Plaque Assay
  • Others

Biomanufacturing Viral Detection and Quantifications Market, By Application:

  • Blood and Blood Products Manufacturing
  • Vaccines and Therapeutics Manufacturing
  • Cellular and Gene Therapy Products Manufacturing
  • Stem Cell Products Manufacturing
  • Tissue and Tissue Products Manufacturing

Biomanufacturing Viral Detection and Quantifications Market, By End User:

  • Life Science Companies
  • Testing Laboratories
  • CROs and CDMOs

Biomanufacturing Viral Detection and Quantifications Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Asia-Pacific

  • China
  • India
  • South Korea
  • Australia
  • Japan

Europe

  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biomanufacturing Viral Detection and Quantifications Market.

Available Customizations:

Global Biomanufacturing Viral Detection and Quantifications Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biomanufacturing Viral Detection and Quantifications Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Offering Type (Consumables, Instruments, Services)
    • 5.2.2. By Technology (PCR, ELISA, FLOW Cytometry, Plaque Assay, Others)
    • 5.2.3. By Application (Blood and Blood Products Manufacturing, Vaccine and Therapeutics Manufacturing, Cellular and Gene Therapy Products Manufacturing, Stem Cell Products Manufacturing, Tissue and tissue Products Manufacturing)
    • 5.2.4. By End-User (Life Science Companies, testing Laboratories, CROs and CDMOs)
    • 5.2.5. By Company (2024)
    • 5.2.6. By Region
  • 5.3. Market Map

6. North America Biomanufacturing Viral Detection and Quantifications Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Offering Type
    • 6.2.2. By Technology
    • 6.2.3. By Application
    • 6.2.4. By End-User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Offering Type
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End-User
    • 6.3.2. Mexico Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Offering Type
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End-User
    • 6.3.3. Canada Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Offering Type
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End-User

7. Europe Biomanufacturing Viral Detection and Quantifications Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Offering Type
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Offering Type
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End-User
    • 7.3.2. Germany Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Offering Type
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End-User
    • 7.3.3. United Kingdom Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Offering Type
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End-User
    • 7.3.4. Italy Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Offering Type
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End-User
    • 7.3.5. Spain Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Offering Type
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End-User

8. Asia-Pacific Biomanufacturing Viral Detection and Quantifications Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Offering Type
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Offering Type
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End-User
    • 8.3.2. India Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Offering Type
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End-User
    • 8.3.3. South Korea Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Offering Type
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End-User
    • 8.3.4. Japan Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Offering Type
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End-User
    • 8.3.5. Australia Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Offering Type
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End-User

9. South America Biomanufacturing Viral Detection and Quantifications Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Offering Type
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Offering Type
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End-User
    • 9.3.2. Argentina Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Offering Type
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End-User
    • 9.3.3. Colombia Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Offering Type
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End-User

10. Middle East and Africa Biomanufacturing Viral Detection and Quantifications Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Offering Type
    • 10.2.2. By Technology
    • 10.2.3. By Application
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Offering Type
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End-User
    • 10.3.2. Saudi Arabia Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Offering Type
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End-User
    • 10.3.3. UAE Biomanufacturing Viral Detection and Quantifications Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Offering Type
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Danaher Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Merck KGaA
  • 15.3. New England Biolabs
  • 15.4. TAKARA HOLDINGS INC.
  • 15.5. Thermo Fisher Scientific Inc.
  • 15.6. Agilent Technologies, Inc.
  • 15.7. Sartorius AG
  • 15.8. Charles River Laboratories
  • 15.9. Bio-Rad Laboratories, Inc.
  • 15.10. PerkinElmer, Inc

16. Strategic Recommendations

17. About Us & Disclaimer